Filana Therapeutics, Inc. (FLNA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Filana Therapeutics, Inc. (FLNA) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

FLNA Cash Flow Statement

Filana Therapeutics, Inc. (FLNA) cash flow statement — 27-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-6.09M	-3.85M	-	-9.75M	-6.22M	-	-11.34M	-61.27M	-18.3M	-18.24M	-19.13M	-22.32M	-26.53M	-19.92M	-13.26M	-21.32M	-21.55M	-11.11M	-23.53M	-7.99M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	2.04%	-	-	84.09%	66%	-	-	-	-	-	-44.3%	-4.67%	-23.11%	-79.27%	43.67%	-166.93%	-45.96%	-116.27%	-920.38%	-579.74%
Net Income	-10.73M	-8.6M	-	-12.54M	-10.81M	-	-23.4M	-27.6M	-27.94M	6.16M	25.04M	-20.92M	-25.65M	-26.38M	-24.27M	-19.13M	-20.26M	-19.33M	-17.53M	-14.17M
Depreciation & Amortization	210K	300K	-	367K	131K	-	220K	260K	259K	300K	311K	356K	392K	391K	391K	389K	300K	299K	313K	313K
Stock-Based Compensation	3.48M	0	-	0	4.4M	-	0	5.74M	5.61M	0	2.33M	2.13M	949K	835K	673K	616K	470K	485K	495K	522K
Deferred Taxes	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	4.63M	0	0	0	0
Other Non-Cash Items	-1.48M	4.01M	-	5.37M	0	-	5.22M	0	0	-62.54M	-43.04M	0	0	0	0	-4.63M	0	0	0	0
Working Capital Changes	2.43M	433K	-	-2.95M	53K	-	6.62M	-39.67M	3.78M	37.84M	-3.77M	-3.88M	-2.22M	5.23M	9.95M	-3.19M	-2.06M	7.43M	-6.81M	5.35M
Change in Receivables	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.48M	102K	-	-4.13M	2.96M	-	538K	-44.59M	-308K	42.95M	-970K	1.08M	-846K	2.1M	4.57M	143K	-1.22M	1.43M	-3.79M	4.78M
Cash from Investing	-31K	-21K	-	-501K	-80K	-	0	-57K	-17K	-29K	0	-41K	-22K	6K	-357K	335K	-1.16M	-1.47M	-425K	-100K
Capital Expenditures	-31K	-21K	-	-501K	-80K	-	0	-57K	-17K	-29K	0	-41K	-22K	6K	-357K	335K	-1.16M	-1.47M	-425K	-100K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	1.68M	-16K	-	-329K	0	-	90K	918K	0	101.39M	22.16M	1.14M	464K	889K	64K	47.34M	136K	119K	211K	0
Debt Issued (Net)	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	-	-329K	0	-	90K	0	0	101.39M	1000K	1000K	464K	889K	64K	1000K	136K	119K	211K	0
Dividends Paid	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	1.68M	-16K	-	0	0	-	0	918K	0	0	0	0	0	0	0	9K	0	0	0	0
Net Change in Cash	-4.44M	-3.89M	-	-10.58M	-6.3M	-	-11.25M	-60.4M	-18.31M	83.12M	3.03M	-21.21M	-26.09M	-19.03M	-13.55M	26.35M	-22.57M	-12.46M	-23.74M	-8.09M
Free Cash Flow	-6.13M	-3.88M	-	-10.25M	-6.3M	-	-11.34M	-61.32M	-18.31M	-18.27M	-19.13M	-22.36M	-26.55M	-19.92M	-13.61M	-20.98M	-22.71M	-12.58M	-23.95M	-8.09M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	2.79%	-	-	83.29%	65.59%	-	-	-	-	-	-40.52%	-6.54%	-16.94%	-58.33%	43.18%	-159.49%	38.31%	-141.37%	-938.81%	-588.26%
FCF per Share	-0.13	-0.08	-	-0.21	-0.13	-	-0.23	-0.01	-0.38	-0.40	-0.43	-0.53	-0.63	-0.48	-0.33	-0.51	-0.57	-0.31	-0.60	-0.20
FCF Conversion (FCF/Net Income)	0.57x	0.45x	-	0.78x	0.58x	-	0.48x	2.22x	0.65x	-2.96x	-0.76x	1.07x	1.03x	0.76x	0.55x	1.11x	1.06x	0.58x	1.34x	0.56x
Interest Paid	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0